Holen Sie sich die Stockscreener-App
3.735
0.00%
0.00
Handel nachbörslich:
3.74
0.005
+0.13%
Schlusskurs vom Vortag:
$3.735
Offen:
$3.7
24-Stunden-Volumen:
5,136
Relative Volume:
0.14
Marktkapitalisierung:
$48.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.87M
KGV:
-8.30
EPS:
-0.45
Netto-Cashflow:
$-767.30K
1W Leistung:
-6.39%
1M Leistung:
-22.74%
6M Leistung:
-71.60%
1J Leistung:
-49.70%
1-Tages-Spanne:
$3.66
$3.84
1-Wochen-Bereich:
$3.66
$3.9518
52-Wochen-Spanne:
$3.03
$32.44
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Vergleichen Sie RGC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGC
Regencell Bioscience Holdings Ltd
|
3.735 | 48.60M | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
174.29 | 78.63B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.85 | 44.54B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 42.61B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.59 | 18.79B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
127.56 | 13.55B | 612.78M | -86.37M | -62.91M | -0.87 |
Regencell Bioscience Holdings Ltd Aktie (RGC) Neueste Nachrichten
Regencell Bioscience Extends Lock-Up Period for Stock Options - TipRanks
Regencell Bioscience Holdings Limited's (NASDAQ:RGC) most bullish insider is CEO Yat-Gai Au, and their holdings value went up by 74% last week - Simply Wall St
Regencell Bioscience Holdings (NASDAQ:RGC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
RGC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Regencell Bioscience (NASDAQ:RGC) Stock Quotes, Forecast and News Summary - Benzinga
Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish - Investing.com
Geron: Derisked And Highly Attractive After Approval (NASDAQ:GERN) - Seeking Alpha
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference - StockTitan
RBC says Regeneron reaction to biosimilar court ruling ‘overdone’ - TipRanks
Insider’s View: Deciphering Regenxbio Inc (RGNX)’s Financial Health Through Ratios - The Dwinnex
Xponance Inc. Lowers Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
40 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Itau Unibanco Holding S.A. - Defense World
Morse Asset Management Inc Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Regency Centers Co. (NASDAQ:REG) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ProShare Advisors LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Is Regenx Tech (CSE:RGX) Using Too Much Debt? - Simply Wall St
Benjamin F. Edwards & Company Inc. Purchases 612 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Profund Advisors LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Legacy Financial Advisors Inc. Purchases 69 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Ensign Peak Advisors Inc Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Ieq Capital LLC Purchases 507 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Trust Investment Advisors Acquires Shares of 192 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
ASB Consultores LLC Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
SYSTM Wealth Solutions LLC Sells 1,244 Shares of Regency Centers Co. (NASDAQ:REG) - Defense World
Intech Investment Management LLC Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
MRP Capital Investments LLC Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Meiji Yasuda Asset Management Co Ltd. Purchases 119 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Moors & Cabot Inc. Has $858,000 Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Wealth Alliance Sells 13 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Argent Trust Co Has $2.49 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Meiji Yasuda Life Insurance Co Sells 2,609 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Envestnet Asset Management Inc. - Defense World
Regency Centers (NASDAQ:REG) Stock Rating Lowered by Evercore ISI - Defense World
RGC’s 52-Week Rollercoaster: From $3.03 to $32.44 – What’s Next for Investors? - The InvestChronicle
Wall Street today: US stocks trade higher after promising inflation data raises Fed rate cut bets; 3M Co. gains 18.99% - Mint
Regencell Bioscience Holdings Limited's (NASDAQ:RGC) most bullish insider, CEO Yat-Gai Au must be pleased with the recent 321% gain - Yahoo Finance
United States shares lower at close of trade; Dow Jones Industrial Average down 0.14% - Investing.com India
What Is Going on With Regencell Bioscience (RGC) Stock Today? - InvestorPlace
CPIX Stock Quote Price and Forecast - CNN
RGC Stock Quote Price and Forecast - CNN
Regencell Bioscience Holdings Limited (NASDAQ:RGC) CEO Yat-Gai Au's holdings dropped 16% in value as a result of the recent pullback - Yahoo Finance
Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation - Simply Wall St
15 Developed Countries with Lowest Autism Rates - Yahoo Finance
With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future - Yahoo Finance
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial - Business Wire
Game-Stop Or Game-On? RGC Has It All And Twice More - ValueWalk
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO - Business Wire
RGC: Regencell BioscienceInvestigational Liquid-Formula RGC-COV19™ Shows Promise in Eliminating COVID-19 Symptoms - Yahoo Finance
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment - SEC.gov
63 Biggest Movers From Yesterday - Yahoo Finance
Finanzdaten der Regencell Bioscience Holdings Ltd-Aktie (RGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.34%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):